Risk Stratification to Predict Renal Survival in Anti–Glomerular Basement Membrane Disease
暂无分享,去创建一个
M. Kollár | V. Tesar | M. Little | D. Geetha | Lauren Floyd | S. McAdoo | M. Srikantharajah | A. Dhaygude | N. Brown | Bilal Khurshid | Jennifer Scott | D. Frausová | S. Brix | Faten Aqeel | Graeme Reid | L. Floyd | Sebastian Bate | Abdul Kafagi | Marek Mysilvecek | Phuong Le Kieu | M. Kollar
[1] V. Tesar,et al. Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study , 2022, Journal of the American Society of Nephrology : JASN.
[2] Jie Feng,et al. Meta-Analytical Accuracy of ANCA Renal Risk Score for Prediction of Renal Outcome in Patients With ANCA-Associated Glomerulonephritis , 2022, Frontiers in Medicine.
[3] B. Rovin,et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.
[4] H. Vrielink,et al. Analyses of registry data of patients with anti-GBM and antineutrophil cytoplasmatic antibody-associated (ANCA) vasculitis treated with or without therapeutic apheresis. , 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[5] A. Aouba,et al. ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature. , 2021, Autoimmunity reviews.
[6] S. Van Laecke,et al. Recurrence and Outcome of Anti−Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation , 2021, Kidney international reports.
[7] D. Geetha,et al. Keeping Up with the Times: Prognostic Tools in ANCA-Associated Glomerulonephritis. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[8] J. Mölne,et al. The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease. , 2019, Kidney international.
[9] D. Annane,et al. Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients , 2019, Front. Immunol..
[10] U. Panzer,et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. , 2018, Kidney international.
[11] R. Wolterbeek,et al. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis. , 2018, Clinical journal of the American Society of Nephrology : CJASN.
[12] V. Tesar,et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients , 2017, Kidney international.
[13] S. Nasr,et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. , 2016, Kidney international.
[14] K. Farrington,et al. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] Gary S Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.
[16] David W. Johnson,et al. Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. , 2013, Kidney international.
[17] A. Salama,et al. Update on antiglomerular basement membrane disease , 2011, Current opinion in rheumatology.
[18] Ming-hui Zhao,et al. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. , 2009, Kidney international.
[19] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[20] L. Revert,et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. , 1991, Clinical nephrology.
[21] D. Jayne,et al. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. , 1990, Kidney international.
[22] V. Schuster,et al. Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease. , 1987, Human pathology.